Health care & policy news you might have missed last week

Slingshot AI will withdraw its therapy chatbot app Ash from the U.K. over concerns it runs afoul of medical device regulations.

These could arguably be the largest changes ever to cell and gene therapy oversight in the U.S.

Experts worry that health officials' use of 'shared decision-making' in new vaccine guidance distorts the concept's meaning and disregards the importance of evidence.

Firing the advisory panel's members could be a first step toward revamping the vaccine injury compensation system.

In a surprise move, Florida officials have proposed drastically reducing eligibility for the state AIDS drug assistance program.

An eczema pill in development from Corvus Pharmaceuticals helped improve patients' skin in an early study.

And other health news from Morning Rounds

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to withhold new medicines